Dermapharm Holding SE
XETRA:DMP

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
XETRA:DMP
Watchlist
Price: 33.65 EUR 7.51% Market Closed
Market Cap: 1.8B EUR
Have any thoughts about
Dermapharm Holding SE?
Write Note

Relative Value

The Relative Value of one DMP stock under the Base Case scenario is 60.37 EUR. Compared to the current market price of 33.65 EUR, Dermapharm Holding SE is Undervalued by 44%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

DMP Relative Value
Base Case
60.37 EUR
Undervaluation 44%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
57
Median 3Y
2
Median 5Y
2.7
Industry
2.6
Forward
1.5
vs History
66
vs Industry
13
Median 3Y
19.9
Median 5Y
23.8
Industry
23
Forward
16.5
vs History
74
vs Industry
34
Median 3Y
9.8
Median 5Y
12
Industry
17.8
vs History
9
vs Industry
34
Median 3Y
11.7
Median 5Y
13.6
Industry
25.4
vs History
96
vs Industry
24
Median 3Y
4.1
Median 5Y
5.8
Industry
2.2
vs History
98
vs Industry
44
Median 3Y
2.7
Median 5Y
3.2
Industry
2.8
Forward
2.2
vs History
98
vs Industry
50
Median 3Y
4.1
Median 5Y
5.4
Industry
5.4
vs History
84
vs Industry
33
Median 3Y
9.4
Median 5Y
10.2
Industry
13.7
Forward
8.5
vs History
73
vs Industry
26
Median 3Y
13.1
Median 5Y
15.2
Industry
17.2
Forward
12.4
vs History
66
vs Industry
27
Median 3Y
12.9
Median 5Y
14.5
Industry
16.5
vs History
66
vs Industry
20
Median 3Y
16.6
Median 5Y
18.8
Industry
19.3
vs History
98
vs Industry
48
Median 3Y
1.8
Median 5Y
2.5
Industry
2

Multiples Across Competitors

DMP Competitors Multiples
Dermapharm Holding SE Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Dermapharm Holding SE
XETRA:DMP
1.8B EUR 1.6 21.8 9.1 13.6
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.5B USD 18.5 90.4 48.6 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
364.1B USD 4.2 24.8 12 15.6
US
Merck & Co Inc
NYSE:MRK
248.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.5 169.4 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
DE
Dermapharm Holding SE
XETRA:DMP
Average P/E: 31.8
21.8
122%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.8
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top